Healthcare Professional’s Experiences & Perceptions of Switching Brands of oral SACT – Survey

Dear BOPA members

In cancer care, little is known about the impact of specific brands of oral SACT medication or how healthcare professionals respond and process brand switches of oral SACT. To understand this, we would like to gather the views of healthcare professionals involved in cancer care, on their perspectives and experiences on brand switching of oral SACT. Insights will be combined with data from the NIHR-funded SWITCH project, to improve cancer treatment delivery.

We would be very grateful if you would complete this online survey, which will take 10-15 minutes, by scanning the QR code or through this link: https://qualtrics.ucl.ac.uk/jfe/form/SV_dj0l16wIjCFIbWe

If you have any problems please email Pinkie Chambers : [email protected]

We would like responses by November 28th

Many thanks
Jessica Lim

4th Year MPharm Student, UCL School of Pharmacy

Supervisors: Dr Pinkie Chambers, Dr Zoe Moon, Rebecca Todd

Latest News

By Suriya Marshall on 14th March 2026

Parliamentary Intervention Sparks National Campaign to Protect NHS Staff from Hazardous Medicinal Products (HMPs)

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster London, 10 March 2026: Today, the Safer Healthcare and Biosafety Network (SHBN) launches…

Read article
By Suriya Marshall on 14th March 2026

Clinical Pharmacy Congress. 8th-9th May 2026

Dear BOPA member, We are excited to announce that we have partnered with Clinical Pharmacy Congress 2026. Clinical Pharmacy Congress is the UK’s leading event for clinical pharmacy professionals working across…

Read article
By BOPA Executive Committee on 13th March 2026

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster

London, 10 March 2026: The Safer Healthcare and Biosafety Network (SHBN) launches a new campaign titled “Protecting Healthcare Workers: Safer Handling of Hazardous Medicinal Products” to raise awareness of the dangers…

Read article
By BOPA on 13th March 2026

Invitation to Participate: SWEET-PLUS Study

You are invited to take part in a research study called SWEET-PLUS (NIHR Research for Patient Benefit: 207952), run by Newcastle and Oxford Brookes Universities. SWEET-PLUS aims to understand experiences…

Read article